Abstract: Prostaglandin F2a analogs, commonly prescribed for glaucoma treatment in ophthalmology, have been reported to induce adverse reactions such as cutaneous hypertrichosis and hyperpigmentation. Therefore, it have been applied to treat alopecia and disorders of hypopigmentation, mainly contains androgenic alopecia, alopecia areata, chemotherapy-induced alopecia, vitiligo, and postinflammatory hypopigmentation.

Key words: prostaglandin F2ɑ analog, bimatoprost, latanoprost, alopecia areata, androgenic alopecia, vitiligo